GlassScriptPhysician profile
Stephen Michael Gollomp
NPI 1194723585
$144,487.56
in general payments reported to CMS, 2019-2025
60 companies · $29K in 2025
The $29K reported for 2025 was more than what 94% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $20K · 2021: $19K · 2022: $17K · 2023: $33K · 2024: $3,776 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $13K · Food and Beverage: $9,250 · Education: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,371.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,095.00 |
| Travel and Lodging | $13,146.65 |
| Food and Beverage | $9,250.36 |
| Education | $1,390.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $54,466.79 | 2019-2025 | Ongentys, Ingrezza |
| Merz North America, INC. | $29,214.42 | 2019-2023 | Xeomin |
| Merz Pharmaceuticals, LLC | $13,664.46 | 2021-2025 | Xeomin, Inbrija |
| Abbvie INC. | $9,994.42 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $8,597.50 | 2019-2022 | |
| Kyowa Kirin, INC. | $7,008.89 | 2019-2024 | Nourianz |
| Allergan, INC. | $3,991.53 | 2019-2021 | |
| Boston Scientific Corporation | $2,486.43 | 2019-2025 | General - Therapies, General - Dbs, Vercise |
| Mdd US Operations, LLC | $2,265.25 | 2020-2025 | Gocovri, Gocovri |
| Acadia Pharmaceuticals INC | $2,216.81 | 2019-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $1,839.09 | 2019-2025 | Ongentys, Crexont, Lyvispah |
| Lilly USA, LLC | $817.43 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Biogen, INC. | $740.06 | 2019-2025 | Vumerity, Tysabri |
| Abbott Laboratories | $679.47 | 2019-2025 | Infinity |
| Sk Life Science, INC. | $678.85 | 2022-2025 | Xcopri |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $593.93 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $388.85 | 2019-2025 | |
| Pfizer INC. | $360.51 | 2023-2025 | |
| Argenx US, INC. | $327.22 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $314.58 | 2019-2025 | Nayzilam |
| Medtronic, INC. | $313.30 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $288.38 | 2019-2025 | Ultomiris |
| Tg Therapeutics, INC. | $258.21 | 2023-2025 | |
| Amgen INC. | $251.35 | 2019-2022 | |
| Genentech USA, INC. | $222.33 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Insightec,INC | $198.67 | 2023-2024 | Exablate |
| Sumitomo Pharma America, INC. | $182.19 | 2023 | Aptiom |
| Janssen Pharmaceuticals, INC | $164.46 | 2021-2023 | Ponvory |
| Acorda Therapeutics, INC | $140.84 | 2019-2024 | Inbrija |
| Genzyme Corporation | $127.21 | 2019-2021 | |
| Eisai INC. | $122.00 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $116.33 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $115.43 | 2021 | |
| Ge Healthcare | $111.60 | 2021-2025 | |
| Avanir Pharmaceuticals, INC. | $108.17 | 2019-2022 | |
| Greenwich Biosciences, INC. | $106.98 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $100.55 | 2022 | |
| Emd Serono, INC. | $99.35 | 2019-2025 | Mavenclad |
| Lundbeck LLC | $94.27 | 2024-2025 | Vyepti |
| Adamas Pharmaceuticals, INC. | $90.64 | 2019-2021 | |
| Celgene Corporation | $82.33 | 2023-2025 | Zeposia |
| Upsher-Smith Laboratories LLC | $79.48 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $57.82 | 2022-2024 | Gvoke Hypopen, Keveyis |
| Sanofi-Aventis U.S. LLC | $49.97 | 2020 | |
| Avion Pharmaceuticals | $39.36 | 2022 | |
| Vertical Pharmaceuticals, LLC | $37.47 | 2019 | |
| Jazz Pharmaceuticals INC. | $34.88 | 2023-2024 | |
| Impel Pharmaceuticals LLC | $32.25 | 2025 | Trudhesa |
| Medtronic USA, INC. | $28.61 | 2019-2020 | |
| Akcea Therapeutics, INC. | $22.32 | 2020-2021 | |
| Portola Pharmaceuticals, LLC | $20.14 | 2020 | |
| Banner Life Sciences, LLC | $18.69 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $18.67 | 2019 | |
| Impel Pharmaceuticals INC. | $18.11 | 2022 | |
| Livanova USA, INC. | $17.06 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $15.11 | 2024 | Valtoco |
| Otsuka America Pharmaceutical, INC. | $14.77 | 2023 | Nuedexta |
| Novo Nordisk INC | $14.47 | 2019 | |
| Amarin Pharma, INC. | $13.92 | 2019 | |
| Revance Therapeutics, INC. | $13.38 | 2024 | Daxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Gollomp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.